Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients

Lars Oddershede, Simon Walker, Nicholas Paton, Wolfgang Stöhr, David Dunn, Mark Sculpher

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerA683
TidsskriftValue in Health
Vol/bind17
Udgave nummer7
ISSN1098-3015
DOI
StatusUdgivet - 12 nov. 2014
BegivenhedInternational Society for Pharmacoeconomics and Outcomes Research 17th Annual European Congress - The Amsterdam RAI , Amsterdam, Holland
Varighed: 8 nov. 201412 nov. 2014
Konferencens nummer: 17

Konference

KonferenceInternational Society for Pharmacoeconomics and Outcomes Research 17th Annual European Congress
Nummer17
LokationThe Amsterdam RAI
Land/OmrådeHolland
ByAmsterdam
Periode08/11/201412/11/2014

Emneord

  • HIV
  • HAART
  • Protease Inhibitor
  • Drug Costs
  • University of York

    Lars Oddershede (Gæsteforsker)

    30 okt. 201329 mar. 2014

    Aktivitet: Gæsteophold ved andre institutioner

Citationsformater